Ellex – Lumibird Medical

One Powerful Vision. A Global Outlook. At Ellex, we know that every employee has something important to contribute. Around the globe, our talented team is helping to lead the way in the development of ophthalmic products and new therapies. Whether it’s engineering, product management, IT, accounting, production or sales, all of our employees are helping, in some way, to treat the leading causes of blindness. Ellex is continuously looking for dynamic individuals to help advance the role of ophthalmic technology. We are committed to pioneering integrated medical technologies that help medical professionals to better diagnose and treat patients. Since 1985 we have manufactured and distributed leading-edge ophthalmic laser and imaging technology for use in the fight against blindness. Today, more than 20,000 Ellex laser and ultrasound systems are in use worldwide. We also offer a range of third-party medical devices and technologies. Over the years Ellex has evolved from a manufacturing company of primarily original equipment manufacture (OEM) products, to direct marketing of our own branded products, and a range of third-party products and services, through subsidiaries in the United States, Japan, Germany, France and Australia, and a network of distribution partners in more than 100 countries. In mid-2020, Quantel Medical completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical. The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of eye disease. For additional information about Ellex and its products, please visit: www.ellex.com